Symbiotic Disease- Chronic Bone & Joint Disease and its Modulation
Versandkostenfrei!
Versandfertig in 6-10 Tagen
26,99 €
inkl. MwSt.
PAYBACK Punkte
13 °P sammeln!
Actinidic archaea has been related to human diseases especially chronic bone and joint disease (osteoporosis, osteoarthritis and spondylosis). The growth of endosymbiotic actinidic archaea leads to neanderthalisation of the human mind-body system. Neanderthal metabolonomics has been described in chronic bone and joint disease especially the Warburg phenotype and hyperdigoxinemia. Digoxin produced by archaeal cholesterol catabolism produces neanderthalisation. Prefrontal cortical atrophy and cerebellar hyperplasia has been related to chronic bone and joint disease. This leads on to dysautonomia...
Actinidic archaea has been related to human diseases especially chronic bone and joint disease (osteoporosis, osteoarthritis and spondylosis). The growth of endosymbiotic actinidic archaea leads to neanderthalisation of the human mind-body system. Neanderthal metabolonomics has been described in chronic bone and joint disease especially the Warburg phenotype and hyperdigoxinemia. Digoxin produced by archaeal cholesterol catabolism produces neanderthalisation. Prefrontal cortical atrophy and cerebellar hyperplasia has been related to chronic bone and joint disease. This leads on to dysautonomia with sympathetic hyperactivity and parasympathetic neuropathy in chronic bone and joint disease. A method to modulate archaeal symbiosis and interconverting homo sapien to homo neanderthalis and vice versa is described. This is done by a high fibre versus a low fibre diet, administration of antioxidant antibiotic and colonic microflora from human and cow dung. This can be called as a therapeutic archaeal symbiotic modulated human evolution for the treatment of chronic bone and joint disease.
Andere Kunden interessierten sich für
